Search results
What is federal COVID relief money for anyway?
Rhode Island Current via Yahoo News· 6 hours agoAs the daily news headlines detailing the spread of bird flu grow, so does Dr. Leonard Mermel’s anxiety. An infectious disease expert who works as...
Tri-State clinics and trials help patients with long COVID
Local 12 Cincinnati· 6 days agoWhile new cases of the novel SARS-CoV-2 virus are down, infectious disease specialist Dr. Stephen...
COVID-19 virus disrupts protein production: Researcher discusses her recent findings
Phys.org· 5 days agoOne thing we do know: Following infection, it's critical that our cells make new proteins to defend against the virus. Writer Jenni Bozec recently spoke with Yerlici—who is ...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 11 hours agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 4 days agoThe scientists investigated the antibody neutralization response against different variants of SARS-...
Hologic, Inc. (NASDAQ:HOLX) Shares Bought by Lindbrook Capital LLC
ETF DAILY NEWS· 5 days agoLindbrook Capital LLC raised its position in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 16.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission ...
Avian influenza: Johns Hopkins experts available
Newswise· 5 days agoExperts from the Johns Hopkins Bloomberg School of Public Health are available to discuss the issue of avian (H5N1) influenza in dairy cows in the U.S. This includes the Food and Drug Administration ...
Signaturefd LLC Purchases 725 Shares of Hologic, Inc. (NASDAQ:HOLX)
ETF DAILY NEWS· 11 hours agoSignaturefd LLC lifted its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 58.8% during the fourth quarter, according to the company in its most recent Form 13F filing with ...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 6 days agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 4 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...